ImmuCell CorporationICCCNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank93
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$1.65M
↑ 251% vs avg
Percentile
P93
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-1.09M
Historical baseline
PeriodValueYoY Change
TTM$1.65M+200.6%
2024$-1.64M+71.5%
2023$-5.75M-150.0%
2022$-2.30M-993.2%
2021$257385.00+118.7%
2020$-1.38M-44.7%
2019$-954000.00+34.1%
2018$-1.45M-495.5%
2017$-243000.00-127.3%
2016$890204.00-